Adcortyl Intra-articular / Intradermal Injection 10mg/ml Suspension for Injection, 5ml
- Name:
Adcortyl Intra-articular / Intradermal Injection 10mg/ml Suspension for Injection, 5ml
- Company:
Bristol-Myers Squibb Pharmaceuticals uc
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 28/05/20
(Click to Download)XPIL
Package leaflet: Information for the user
Package leaflet: Information for the user
1. What Adcortyl IA/ID Injection is and what it is used for
1. What Adcortyl IA/ID Injection is and what it is used for
2. What you need to know before you are given Adcortyl IA/ID Injection
2. What you need to know before you are given Adcortyl IA/ID Injection
3. Receiving Adcortyl IA/ID Injection
3. Receiving Adcortyl IA/ID Injection
4. Possible side effects
4. Possible side effects
5. How to store Adcortyl IA/ID Injection
5. How to store Adcortyl IA/ID Injection
6. Content of the pack and other information
6. Content of the pack and other information
Summary of Product Characteristics last updated on medicines.ie: 7/8/2018
Click on this link to Download PDF directly
Bristol-Myers Squibb Pharmaceuticals uc
Company Products
| Medicine Name | Active Ingredients |
|---|---|
| Medicine Name Adcortyl Intra-articular / Intradermal Injection 10mg/ml Suspension for Injection, 5ml | Active Ingredients Triamcinolone Acetonide |
| Medicine Name Azactam 1g and 2g Powder for Solution for Injection or Infusion | Active Ingredients Aztreonam |
| Medicine Name Hydrea 500 mg Hard Capsules | Active Ingredients Hydroxycarbamide |
Items Per Page :
1 - 0 of 3 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 28 May 2020 PIL
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 7 August 2018 PIL
Reasons for updating
- New PIL for new product
Updated on 7 August 2018 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 6 December 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 6 December 2017 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Change of name and address of MAH (Previous details: BMS Pharmaceuticals Ltd, Swords, Dublin).
Updated on 6 December 2017 PIL
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
Change of name and address of MAH (Previous details: BMS Pharmaceuticals Ltd, Swords, Dublin).
Updated on 6 April 2017 SPC
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.3 - Preclinical safety data
- Change to section 6.4 - Special precautions for storage
- Change to section 6.5 - Nature and contents of container
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Note that the changes to section 4.4 and 4.5 are in line with PRAC recommendation Nov 2016.
Updated on 6 April 2017 PIL
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.3 - Preclinical safety data
- Change to section 6.4 - Special precautions for storage
- Change to section 6.5 - Nature and contents of container
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Free text change information supplied by the pharmaceutical company
Note that the changes to section 4.4 and 4.5 are in line with PRAC recommendation Nov 2016.
Updated on 1 April 2016 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
In section 4.8 (undesirable effects) added the frequency of the ADRs and updated IMB to HPRA
Updated on 1 April 2016 PIL
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
In section 4.8 (undesirable effects) added the frequency of the ADRs and updated IMB to HPRA
Updated on 20 June 2014 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
PRAC recommendation - update to include 'post menopausal women'.
Updated on 20 June 2014 PIL
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Free text change information supplied by the pharmaceutical company
PRAC recommendation - update to include 'post menopausal women'.
Updated on 7 February 2014 SPC
Reasons for updating
- Change to section 6.4 - Special precautions for storage
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
6.4 Special precautions for storage
Do not store above 25°C.
Do not freeze. Do not freeze or refrigerate. Protect from light.
10. DATE OF (PARTIAL) REVISION OF THE TEXT
August 2011February 2013
Do not store above 25°C.
10. DATE OF (PARTIAL) REVISION OF THE TEXT
Updated on 7 February 2014 PIL
Reasons for updating
- Change to section 6.4 - Special precautions for storage
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
6.4 Special precautions for storage
Do not store above 25°C.
Do not freeze. Do not freeze or refrigerate. Protect from light.
10. DATE OF (PARTIAL) REVISION OF THE TEXT
August 2011February 2013
Do not store above 25°C.
10. DATE OF (PARTIAL) REVISION OF THE TEXT
Updated on 12 July 2012 PIL
Reasons for updating
- Improved electronic presentation
Free text change information supplied by the pharmaceutical company
Improve electronic presentation
Updated on 12 July 2012 SPC
Reasons for updating
- Improved electronic presentation
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Improve electronic presentation
Updated on 29 September 2011 SPC
Reasons for updating
- New individual SPC (was previously included in combined SPC)
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
None provided
Updated on 29 September 2011 PIL
Reasons for updating
- New individual SPC (was previously included in combined SPC)
Free text change information supplied by the pharmaceutical company
None provided